Activation of NLR family, domain of pyrin containing 3 inflammasome by nitrous oxide through thioredoxin-interacting protein to induce nerve cell injury

References

• Garakani A, Jaffe R, Savla D, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016;25(5):358–369.
   PubMed Web of Science ®Google Scholar
• Stentz D, Drum M, Reader A, et al. Effect of a combination of intranasal ketorolac and nitrous oxide on the success of the inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a prospective, randomized, double-blind study. J Endod. 2018;44(1):9–13.
   PubMed Web of Science ®Google Scholar
• Li H, Chu C, Chang K, et al. Clinical and electrodiagnostic characteristics of nitrous oxide-induced neuropathy in Taiwan. Clin Neurophysiol. 2016;127(10):3288–3293.
   PubMed Web of Science ®Google Scholar
• Stewart K, Iskandar B, Meier B, et al. Nitrous oxide impairs axon regeneration after nervous system injury in male rats. Anesthesiology. 2019;131(5):1063–1076.
   PubMed Web of Science ®Google Scholar
• Jevtovic-Todorovic V, Beals J, Benshoff N, et al. Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience. 2003;122(3):609–616.
   PubMed Web of Science ®Google Scholar
• Vionnet N, Hani E, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet. 2000;67(6):1470–1480.
   PubMed Web of Science ®Google Scholar
• Tsubaki H, Tooyama I, Walker D. Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases. Int J Mol Sci. 2020;21(24):9357.
   Web of Science ®Google Scholar
• Alhawiti N, Al Mahri S, Aziz M, et al. TXNIP in metabolic regulation: physiological role and therapeutic outlook. Curr Drug Targets. 2017;18(9):1095–1103.
   PubMed Web of Science ®Google Scholar
• Park H, Song J, Park J, et al. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Autophagy. 2020; 1–16. 10.1080/15548627.2020.1834711
   PubMed Web of Science ®Google Scholar
• Li Y, Li J, Li S, et al. Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP/NLRP3 inflammasome activation in a manner dependent on AMPK. Toxicol Appl Pharmacol. 2015;286(1):53–63.
   PubMed Web of Science ®Google Scholar
• Feng L, Zhang L. Resveratrol Suppresses Aβ-Induced Microglial Activation Through the TXNIP/TRX/NLRP3 Signaling Pathway. DNA Cell Biol. 2019;38(8):874–879.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Che X, Zhang H, et al. Thioredoxin-interacting protein links endoplasmic reticulum stress to inflammatory brain injury and apoptosis after subarachnoid haemorrhage. J Neuroinflammation. 2017;14(1):104.
   PubMedGoogle Scholar
• Ishrat T, Mohamed I, Pillai B, et al. Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. 2015;51(2):766–778.
   PubMed Web of Science ®Google Scholar
• Su C, Feng Y, Liu T, et al. Thioredoxin-interacting protein induced α-synuclein accumulation via inhibition of autophagic flux: implications for Parkinson’s disease. CNS Neurosci Ther. 2017;23(9):717–723.
   PubMed Web of Science ®Google Scholar
• Yu J, Wu J, Zhang Z, et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 2006;13(2):236–249.
   PubMed Web of Science ®Google Scholar
• Gao P, He F, Tang H, et al. NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia. J Diabetes Res. 2015;2015:504761.
   PubMed Web of Science ®Google Scholar
• Li H, Willingham S, Ting J, et al. Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol (Baltimore, Md: 1950). 2008;181(1):17–21.
   PubMed Web of Science ®Google Scholar
• Luo B, Huang F, Liu Y, et al. NLRP3 Inflammasome as a molecular marker in diabetic Cardiomyopathy. Front Physiol. 2017;8:519.
   PubMed Web of Science ®Google Scholar
• Tsuchiya K. Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor Immunity. Int J Mol Sci. 2021 Jan 4;22(1):1.
   Web of Science ®Google Scholar
• Hew A, Lai E, Radford E. Nitrous oxide abuse presenting with acute psychosis and peripheral neuropathy. Aust N Z J Psychiatry. 2018;52(4):388.
   PubMed Web of Science ®Google Scholar
• Beal J, Cheng Y, Merchant S, et al. An acute, severe axonal sensorimotor polyneuropathy in the setting of nitrous oxide abuse. Neurohospitalist. 2020;10(4):293–296. .
   PubMed Web of Science ®Google Scholar
• Sun W, Liao J, Hu Y, et al. Pulmonary embolism and deep vein thrombosis caused by nitrous oxide abuse: a case report. World J Clin Cases. 2019;7(23):4057–4062.
   PubMed Web of Science ®Google Scholar
• Gitman M, Fettiplace M, Weinberg G, et al. Local anesthetic systemic toxicity: a narrative literature review and clinical update on prevention, diagnosis, and management. Plast Reconstr Surg. 2019;144(3):783–795.
   PubMed Web of Science ®Google Scholar
• Shu Y, Patel S, Pac-Soo C, et al. Xenon pretreatment attenuates anesthetic-induced apoptosis in the developing brain in comparison with nitrous oxide and hypoxia. Anesthesiology. 2010;113(2):360–368.
   PubMed Web of Science ®Google Scholar
• Kaar S, Ferris J, Waldron J, et al. Up: the rise of nitrous oxide abuseAn international survey of contemporary nitrous oxide use. Journal of psychopharmacology (Oxford, England). 2016;30(4):395–401.
   PubMed Web of Science ®Google Scholar
• Imberger G, Orr A, Thorlund K, et al. Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis. Br J Anaesth. 2014;112(3):410–426.
   PubMed Web of Science ®Google Scholar
• Leslie K, Myles P, Devereaux P, et al. Nitrous oxide and serious morbidity and mortality in the POISE trial. Anesth Analg. 2013;116(5):1034–1040.
   PubMed Web of Science ®Google Scholar
• Abraini J, Marassio G, David H, et al. Crystallographic studies with xenon and nitrous oxide provide evidence for protein-dependent processes in the mechanisms of general anesthesia. Anesthesiology. 2014;121(5):1018–1027.
   PubMed Web of Science ®Google Scholar
• Valleggi S, Cavazzana A, Bernardi R, et al. Xenon up-regulates several genes that are not up-regulated by nitrous oxide. J Neurosurg Anesthesiol. 2008;20(4):226–232.
   PubMed Web of Science ®Google Scholar
• Mawhinney LJ, de Rivero Vaccari JP, Alonso OF, et al. Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain. Brain Res. 2012 Jan 11;1431:23–34.
   PubMed Web of Science ®Google Scholar
• Xiong WX, Zhou GX, Wang B, et al. Impaired spatial learning and memory after sevoflurane-nitrous oxide anesthesia in aged rats is associated with down-regulated cAMP/CREB signaling. PLoS One. 2013;8(11):e79408.
   PubMed Web of Science ®Google Scholar
• Sbai O, Devi TS, Melone MA, et al. RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J Cell Sci. Dec. 2010 15;123(24):4332–4339.
   PubMed Web of Science ®Google Scholar
• Stewart KJ, Iskandar BJ, Meier BM, et al. Nitrous oxide impairs axon regeneration after nervous system injury in male rats. Anesthesiology. 2019 Nov;131(5):1063–1076.
   PubMed Web of Science ®Google Scholar
• Tani J, Weng HY, Chen HJ, et al. Elucidating unique axonal dysfunction between nitrous oxide Abuse and Vitamin B12 deficiency. Front Neurol. 2019;10:704.
   PubMed Web of Science ®Google Scholar
• Hou L, Yang J, Li S, et al. Glibenclamide attenuates 2,5-hexanedione-induced neurotoxicity in the spinal cord of rats through mitigation of NLRP3 inflammasome activation, neuroinflammation and oxidative stress. Toxicol Lett. 2020 Oct 1;331:152–158.
   PubMed Web of Science ®Google Scholar
• Zhao T, Xu K, Wu Q, et al. Duraplasty of PHBV/PLA/Col membranes promotes axonal regeneration by inhibiting NLRP3 complex and M1 macrophage polarization in rats with spinal cord injury. Faseb J. 2020 Sep;34(9):12147–12162.
   PubMed Web of Science ®Google Scholar
• Ma M, Li R, Sun W, et al. Sevoflurane preconditioning inhibits cardiomyocyte injury induced by oxygen‑glucose deprivation by modulating TXNIP. Int J Mol Med. 2020;46(2):889–897.
   PubMed Web of Science ®Google Scholar
• Yeda X, Shaoqing L, Yayi H, et al. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats. Acta Cir Bras. 2017;32(6):429–439.
   PubMed Web of Science ®Google Scholar